Shanghai Pharmaceuticals Holding Co., Ltd Goes Ex Dividend on Monday
Tianjin Ringpu Bio-Technology Raises $207 Million From Private Placement
BRIEF-BioKangtai's Adenovirus Vector Covid-19 Vaccine Obtained Eua In Indonesia
Baiyunshan Pharmaceutical's Q3 Profit Jumps 10%
China Resources Sanjiu Logs Higher Net Profit, Revenue in January-September; Shares Slump 10%
Tailong Pharmaceutical Co., Ltd. plans to welcome the new owner, Zhengzhou high-tech production investment is planned to become the actual controller.
On September 23rd, Capital State learned that the controlling shareholder of A-share company Tai long Pharmaceutical (600222.SH) signed the "share transfer Framework Agreement". As of the date of this announcement, Zhengzhou Zhongsheng Industrial Group Co., Ltd. (hereinafter referred to as "Zhongsheng Industry"), the company's controlling shareholder, holds 132 million shares of the company, accounting for 23.08% of the company's total share capital, all of which are tradable shares with unlimited sales conditions. Zhongsheng Industries has pledged a total of 50 million shares of the company, accounting for 37.75% of the shares held and 8.71% of the total share capital of the company. The above-mentioned stock pledge is not expected to pose an obstacle to the progress of the transaction.